Dr. Neal Walker co-founded Aclaris Therapeutics and has served as president and chief executive officer and a member of the board of directors since the company's inception in July 2012.
Dr. Walker co-founded NeXeption, LLC, a biopharmaceutical assets management company, in August 2012. Between July 2011 and July 2012, Dr. Walker served as a consultant to a number of pharmaceutical companies. Dr. Walker co-founded and served as president and chief executive officer and a member of the board of directors of Vicept Therapeutics, Inc., a dermatology-focused specialty pharmaceutical company, from 2009 until its acquisition by Allergan, Inc. in July 2011. Previously, Dr. Walker co-founded and led a number of life science companies, including Octagon Research Solutions, Inc., a software and services provider to biopharmaceutical companies (acquired by Accenture), Trigenesis Therapeutics, Inc., a specialty dermatology company, where he served as chief medical officer (acquired by Dr. Reddy's Laboratories Inc.), and Cutix Inc., a commercial dermatology company.
He began his pharmaceutical industry career at Johnson & Johnson, Inc. Dr. Walker is a director of Alderya Therapeutics, Inc., a publicly held biotechnology company, as well as several private biotechnology companies.
Dr. Walker received his MBA from The Wharton School, University of Pennsylvania, his doctor of osteopathic medicine degree from Philadelphia College of Osteopathic Medicine and a B.A. in Biology from Lehigh University.